Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication
Current standard chemotherapy for late stage ovarian cancer is found unsuccessful due to relapse after completing the regimens. After completing platinum-based chemotherapy, 70% of patients develop relapse and resistance. Recent evidence proves ovarian cancer stem cells as the source of resistance....
Saved in:
| Main Authors: | Yu-kai Su, Wen-Chien Huang, Wei-Hwa Lee, Oluwaseun Adebayo Bamodu, Muhammad Ary Zucha, Indwiani Astuti, Heri Suwito, Chi-Tai Yeh, Chien-Min Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-04-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317691689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling Theranostics: Nanocomplex-Assisted Photodynamic Eradication of Aggressive Cancer Cells and Modulation of Tumor-Associated Macrophages
by: Butkute A, et al.
Published: (2025-08-01) -
Discovery of a novel chalcone-derived covalent Keap1 binder for mitigating cisplatin-induced mitochondrial dysfunction and nephrotoxicity
by: Yanyan Deng, et al.
Published: (2025-09-01) -
Prenylated Chalcones as Anticancer Agents Against Castration-Resistant Prostate Cancer
by: Marcos Morales-Reyna, et al.
Published: (2025-06-01) -
4′-(2-Methoxyphenyl)-2,2′:6′,2′′-terpyridine
by: Eric M. Njogu, et al.
Published: (2024-11-01) -
GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
by: Xin Gong, et al.
Published: (2017-01-01)